Overview
Synkmed is a group of Polish manufacturers of medical equipment collaborating within the Polish Economic Society to enhance business potential and promote economic patriotism. The company focuses on rebuilding economic autonomy in the medical industry, representing the interests of its members, and supporting research and development. Additionally, Synkmed aims to promote Polish products in both domestic and international markets while ensuring a reliable supply chain for medical components.
Financials
The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Financial insight
- Estonian CIT: Equity (Pasywa A) includes non-zero line items under Art. 28d of the Accounting Act — the filing indicates the lump-sum tax on company income.
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2022.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-04-10. Active
26 1240 6074 1111 0011 1062 2810
30 1940 1076 3258 9045 0000 0000- 40 1240 6074 1111 0011 0544 3631
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marek Tadeusz Orzeł (51) | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Marek Tadeusz Orzeł (51)  | Shareholder of a limited liability company, 50000.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| DiagnosisS.A. | $37,413,735.72 | diagnosis.pl | |
| Cirrosp. z o.o. | $25,051,212.29 | cirro.pl | |
| Midas Pharma Polskasp. z o.o. | $20,847,894.51 | midas-pharma.com | |
| SynektikS.A. | $20,028,244.70 | synektik.pl | |
| Camedica Paweł Harasimiuksp. k. | $18,691,613.15 | camedica.pl | |
| Biochem PolskaS.A. | $13,180,007.81 | biochempolska.pl | |
| PolypharmS.A. | $13,084,716.73 | polypharm.pl | |
| PromedS.A. | $12,643,674.56 | promed.com.pl | |
| Nova Group A. Chmielewskisp. k. | $12,556,899.57 | novagroup.pl | |
| MassmedicaS.A. | $8,216,274.00 | massmedica.com |
Change history
| Date | Event |
|---|---|
| 2025-06-02 | PKD change (Removed: 32.50.Z; Added: 77.32.Z) |
| 2024-03-13 | Address change (Ul. Celulozy 107k/2, 04-986, Warszawa → Żurawia 6/12/745, 00-503, Warszawa) |
| 2023-05-25 | Address change (Ul. Bysławska 82, 04-993, Warszawa → Ul. Celulozy 107k/2, 04-986, Warszawa) |
| 2023-05-25 | PKD change (Removed: 27.90.Z, 46.52.Z, 47.74.Z, 70.22.Z, 71.20.B, 72.19.Z; Added: 46.7, 47, 64.19.Z, 64.92.Z, 68, 82.30.Z) |
| 2021-03-31 | Entered in the register |
FAQ
Last updated: 2026-07-09